• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / U.S. Equity

Trending Tickers: TWTR, VRX, ENDP, RIG

It appears Twitter will need more than takeover chatter to stay aloft, Oppenheimer analysts say.
By JAMES PASSERI Sep 26, 2016 | 02:09 PM EDT
Stocks quotes in this article: TWTR, GOOGL, CRM, MYL, VRX, ENDP, RIG

Takeover chatter won't be enough to keep Twitter (TWTR) shares moving skyward, as the social media giant may be overvalued vs. peers.

At least that's what Oppenheimer analyst Jeff Helfstein said in a Monday investment note, downgrading Twitter shares to Underperform from Perform, and adding on CNBC's "Squawk Alley" that a takeover valuation may already be priced in to Twitter's stock price. 

"Number one, we look at what competitors trade at, number two, you look at the fundamentals of the business and the bottom line is we all know that user growth is slowing," he added.

Twitter shares were roughly flat in midday trading after climbing more than 20% Friday on rumors that Salesforce (CRM) and Google parent Alphabet (GOOGL) may be in the hunt with a takeover bid. (Alphabet shares are held in Jim Cramer's Action Alerts PLUS charitable trust.)

Pharmaceutical shares were largely down across the board Monday, as Big Pharma investors braced for tonight's presidential debate between Hillary Clinton and Donald Trump, who appear to be in agreement over cracking down on industry price hikes in the wake of Mylan's (MYL) exorbitant increases on its life-saving allergy treatment EpiPen. 

Shares of struggling drugmaker Valeant Pharmaceuticals (VRX) , which has been specifically targeted by Clinton this year for "predatory pricing," and Endo Pharmaceuticals (ENDP) , which said CEO Rajiv De Silva is resigning Monday, were each down more than 6% in midday trading.

Meanwhile, surging oil prices helped buoy oil-and-gas stocks Monday afternoon, as prices of crude climbed about 3.7% to $46.11, based on industry benchmark West Texas Intermediate. Rising prices failed to lift the general market, however, with the Dow Jones Industrials and S&P 500 each down about 0.8% in midday trading.
 
Shares of  Transocean ( RIG)  , a member of Real Money's Stressed Out watch list, were among the best-performing in the S&P 500, with crude prices lifting shares of the Swiss offshore driller about 5% in midday trading.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from owning individual securities.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, is long Alphabet stock.

TAGS: Investing | U.S. Equity

More from U.S. Equity

4 Reasons to Be Cautiously Optimistic About the Tech Sector

Eric Jhonsa
May 25, 2022 5:15 PM EDT

Many tech valuations are now back to 2016 or 2017 levels, and quite a few contrarian indicators point to extreme bearishness.

Have You Noticed This Shift in the Market?

James "Rev Shark" DePorre
May 25, 2022 11:00 AM EDT

Bonds tend to gain strength, and interest rates decline as worries about a recession increase.

Investor Sentiment Remains at Historically High Levels of Fear

Guy Ortmann
May 25, 2022 10:15 AM EDT

Here's where things stand in this volatile stock market.

Snap Judgement, S&P Basing Pattern? Spiraling Macro, Trading Lithium Stocks

Stephen Guilfoyle
May 25, 2022 7:49 AM EDT

A lot of folks haven't even realized that their 401(k)s and IRAs have been 'smashified' -- and that their homes are not worth what they think.

Overnight Blood, Didn't It Matter? Snap's Whammy, Trading Bank Stocks and Zoom

Stephen Guilfoyle
May 24, 2022 7:35 AM EDT

There was the 'momentum play' on Monday and not much else as portfolio managers resisted temptation to increase risk exposure.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 11:33 AM EDT PETER TCHIR

    Thoughts Ahead of the Fed Minutes

    Recent economic and earnings issues are convincing...
  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login